IFNB1 and cancer: We stimulated BMDMs with Pam3CSK4 in combination with different concentrations of either IFN-γ, IFN-β, or the other major type I IFN, IFN-α (type A), for 24 h before analyzing NO production and growth inhibition of LLC cancer cells.